Healthy Subjects clinical trials

Explore recruiting healthy subjects clinical trials.

Recruiting healthy subjects studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Subjects trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, balanced, two-treatment, two-sequence, single oral dose, two stage crossover adaptative bioequivalence study of Rifaximin 200 mg film-coated tablets (Antibiotice SA) vs. Normix® 200 mg, film- coated tablets (Alfasigma S.P.A) in healthy subjects under fed conditions

Romania

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Study to assess the relative bioavailability of Neludolat versus YAZ in healthy female subjects.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

EEG-MRI Study of the Effect of Methylphenidate on Neural Mechanisms in Adult Patients With ADHD With or Without Mood Disorders: a Randomized Controlled Trial Versus Placebo

France

Phase II and Phase III (Integrated) EU CTIS Study details

Impact of epilepsy on the brainstem adenosine pathway and its relation with arousal and respiratory reactivity BRAVE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Single Dose, Fed state, Crossover Replicate, Bioequivalence Study of Naproxen 500 mg/ Esomeprazole 20 mg modified-release tablets (Antibiotice S.A.) versus Vimovo® 500 mg/20 mg film coated tablets (Grunenthal GmbH)

Romania

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FURABID® 100 mg prolonged-release capsules (Amdipharm Limited)

Romania

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Healthy Subjects trials by city

Healthy Subjects in Toronto Healthy Subjects in Vancouver Healthy Subjects in Montreal Healthy Subjects in Calgary Healthy Subjects in Edmonton Healthy Subjects in Ottawa Healthy Subjects in Winnipeg Healthy Subjects in Quebec City Healthy Subjects in Hamilton Healthy Subjects in Kitchener Healthy Subjects in London Healthy Subjects in Halifax Healthy Subjects in New York Healthy Subjects in Los Angeles Healthy Subjects in Chicago Healthy Subjects in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease